Modified Release Formulations Market

Future Market Insights

Modified Release Formulations Market

Key Insight

The modified release formulations market is expected to grow from USD 282.1 billion in 2025 to USD 524.7 billion by 2035, progressing at a CAGR of 6.4%. Among all release mechanisms, extended-release dosage forms are projected to hold the largest share at 41.2%, while matrix tablets dominate formulation type with a 29.0% share in 2025.

July 02, 2025

Anurag Sharma

250 Pages

Cite this Report

Modified Release Formulations Market

https://www.futuremarketinsights.com/reports/modified-release-formulations-market

License

Buy Now

Summary ToC Companies

Key Players

Adare Pharma Solutions
Adragos Pharma
BioDuro
Catalent Inc
Mayne Pharma Inc
Quotient Sciences
Recipharm AB
Societal CDMO
Syngene International Limited
Zocalo Pharmaceutical Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Modified Release Formulations Market

Key Players

Similar Industry Reports